Feroz Sarkari

1.1k total citations
10 papers, 930 citations indexed

About

Feroz Sarkari is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Feroz Sarkari has authored 10 papers receiving a total of 930 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Oncology and 3 papers in Epidemiology. Recurrent topics in Feroz Sarkari's work include Ubiquitin and proteasome pathways (7 papers), Viral-associated cancers and disorders (4 papers) and Cancer-related Molecular Pathways (3 papers). Feroz Sarkari is often cited by papers focused on Ubiquitin and proteasome pathways (7 papers), Viral-associated cancers and disorders (4 papers) and Cancer-related Molecular Pathways (3 papers). Feroz Sarkari collaborates with scholars based in Canada, India and United States. Feroz Sarkari's co-authors include Lori Frappier, V. Saridakis, C.H. Arrowsmith, Yi Sheng, Nirojini Sivachandran, Yi Sheng, Shili Duan, Tin Nguyen, Kathy Shire and Weontae Lee and has published in prestigious journals such as Journal of Biological Chemistry, Molecular Cell and PLoS ONE.

In The Last Decade

Feroz Sarkari

10 papers receiving 918 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Feroz Sarkari Canada 9 659 518 228 120 114 10 930
Kathy Shire Canada 13 530 0.8× 568 1.1× 315 1.4× 150 1.3× 147 1.3× 18 1.0k
Meir Shamay United States 15 349 0.5× 436 0.8× 463 2.0× 114 0.9× 80 0.7× 31 912
Christopher B. Whitehurst United States 16 282 0.4× 391 0.8× 264 1.2× 153 1.3× 49 0.4× 22 676
Josephine N. Harada United States 9 460 0.7× 470 0.9× 187 0.8× 161 1.3× 398 3.5× 11 893
Ulrich K. Binné United Kingdom 8 502 0.8× 466 0.9× 126 0.6× 82 0.7× 52 0.5× 8 787
Xiufen Lei United States 14 519 0.8× 740 1.4× 431 1.9× 171 1.4× 32 0.3× 27 1.2k
Andreas Wiedmer United States 16 802 1.2× 578 1.1× 418 1.8× 146 1.2× 80 0.7× 23 1.4k
Robert Touitou United Kingdom 10 302 0.5× 528 1.0× 145 0.6× 158 1.3× 38 0.3× 10 742
Magdalena Weidner-Glunde Germany 15 317 0.5× 600 1.2× 485 2.1× 199 1.7× 102 0.9× 16 992
Xianming Yu United States 16 253 0.4× 403 0.8× 398 1.7× 180 1.5× 62 0.5× 20 793

Countries citing papers authored by Feroz Sarkari

Since Specialization
Citations

This map shows the geographic impact of Feroz Sarkari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feroz Sarkari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feroz Sarkari more than expected).

Fields of papers citing papers by Feroz Sarkari

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Feroz Sarkari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feroz Sarkari. The network helps show where Feroz Sarkari may publish in the future.

Co-authorship network of co-authors of Feroz Sarkari

This figure shows the co-authorship network connecting the top 25 collaborators of Feroz Sarkari. A scholar is included among the top collaborators of Feroz Sarkari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Feroz Sarkari. Feroz Sarkari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Wheaton, Keith, Feroz Sarkari, Olga Egorova, et al.. (2017). UbE2E1/UBCH6 Is a Critical in Vivo E2 for the PRC1-catalyzed Ubiquitination of H2A at Lys-119. Journal of Biological Chemistry. 292(7). 2893–2902. 22 indexed citations
2.
Sarkari, Feroz, Keith Wheaton, Anthony La Delfa, et al.. (2013). Ubiquitin-specific Protease 7 Is a Regulator of Ubiquitin-conjugating Enzyme UbE2E1. Journal of Biological Chemistry. 288(23). 16975–16985. 39 indexed citations
3.
Sarkari, Feroz, et al.. (2013). The Role of Support Services in Promoting Social Inclusion for the Disadvantaged Urban-dwelling Elderly. Canadian Geriatrics Journal. 16(4). 156–179. 7 indexed citations
4.
Sarkari, Feroz, Xueqi Wang, Tin Nguyen, & Lori Frappier. (2011). The Herpesvirus Associated Ubiquitin Specific Protease, USP7, Is a Negative Regulator of PML Proteins and PML Nuclear Bodies. PLoS ONE. 6(1). e16598–e16598. 45 indexed citations
5.
Sarkari, Feroz, Anthony La Delfa, C.H. Arrowsmith, et al.. (2010). Further Insight into Substrate Recognition by USP7: Structural and Biochemical Analysis of the HdmX and Hdm2 Interactions with USP7. Journal of Molecular Biology. 402(5). 825–837. 46 indexed citations
6.
Sarkari, Feroz, Yi Sheng, & Lori Frappier. (2010). USP7/HAUSP Promotes the Sequence-Specific DNA Binding Activity of p53. PLoS ONE. 5(9). e13040–e13040. 23 indexed citations
7.
Sarkari, Feroz, et al.. (2009). EBNA1-Mediated Recruitment of a Histone H2B Deubiquitylating Complex to the Epstein-Barr Virus Latent Origin of DNA Replication. PLoS Pathogens. 5(10). e1000624–e1000624. 93 indexed citations
8.
Sivachandran, Nirojini, Feroz Sarkari, & Lori Frappier. (2008). Epstein-Barr Nuclear Antigen 1 Contributes to Nasopharyngeal Carcinoma through Disruption of PML Nuclear Bodies. PLoS Pathogens. 4(10). e1000170–e1000170. 122 indexed citations
9.
Sheng, Yi, V. Saridakis, Feroz Sarkari, et al.. (2006). Molecular recognition of p53 and MDM2 by USP7/HAUSP. Nature Structural & Molecular Biology. 13(3). 285–291. 249 indexed citations
10.
Saridakis, V., Yi Sheng, Feroz Sarkari, et al.. (2005). Structure of the p53 Binding Domain of HAUSP/USP7 Bound to Epstein-Barr Nuclear Antigen 1. Molecular Cell. 18(1). 25–36. 284 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026